Impact of Low-dose Tamoxifen on BPU
NCT02979301
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
High Background Uptake on MBI
Interventions
DRUG:
Tamoxifen
Sponsor
Mayo Clinic